These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
282 related items for PubMed ID: 16288224
1. HEF1 is a necessary and specific downstream effector of FAK that promotes the migration of glioblastoma cells. Natarajan M, Stewart JE, Golemis EA, Pugacheva EN, Alexandropoulos K, Cox BD, Wang W, Grammer JR, Gladson CL. Oncogene; 2006 Mar 16; 25(12):1721-32. PubMed ID: 16288224 [Abstract] [Full Text] [Related]
2. Focal adhesion kinase regulates beta1 integrin-dependent T cell migration through an HEF1 effector pathway. van Seventer GA, Salmen HJ, Law SF, O'Neill GM, Mullen MM, Franz AM, Kanner SB, Golemis EA, van Seventer JM. Eur J Immunol; 2001 May 16; 31(5):1417-27. PubMed ID: 11465098 [Abstract] [Full Text] [Related]
3. Inhibition of focal adhesion kinase expression or activity disrupts epidermal growth factor-stimulated signaling promoting the migration of invasive human carcinoma cells. Hauck CR, Sieg DJ, Hsia DA, Loftus JC, Gaarde WA, Monia BP, Schlaepfer DD. Cancer Res; 2001 Oct 01; 61(19):7079-90. PubMed ID: 11585739 [Abstract] [Full Text] [Related]
4. Differential effect of the focal adhesion kinase Y397F mutant on v-Src-stimulated cell invasion and tumor growth. Chang LC, Huang CH, Cheng CH, Chen BH, Chen HC. J Biomed Sci; 2005 Oct 01; 12(4):571-85. PubMed ID: 16132110 [Abstract] [Full Text] [Related]
5. Different modes and qualities of tyrosine phosphorylation of Fak and Pyk2 during epithelial-mesenchymal transdifferentiation and cell migration: analysis of specific phosphorylation events using site-directed antibodies. Nakamura K, Yano H, Schaefer E, Sabe H. Oncogene; 2001 May 10; 20(21):2626-35. PubMed ID: 11420674 [Abstract] [Full Text] [Related]
13. Focal adhesion targeting of v-Crk is essential for FAK phosphorylation and cell migration in mouse embryo fibroblasts deficient src family kinases or p130CAS. Yeo MG, Sung BH, Oh HJ, Park ZY, Marcantonio EE, Song WK. J Cell Physiol; 2008 Mar 10; 214(3):604-13. PubMed ID: 17786957 [Abstract] [Full Text] [Related]
14. Tumor suppressor PTEN inhibition of cell invasion, migration, and growth: differential involvement of focal adhesion kinase and p130Cas. Tamura M, Gu J, Takino T, Yamada KM. Cancer Res; 1999 Jan 15; 59(2):442-9. PubMed ID: 9927060 [Abstract] [Full Text] [Related]
15. Human enhancer of filamentation 1-induced colorectal cancer cell migration: Role of serine phosphorylation and interaction with the breast cancer anti-estrogen resistance 3 protein. Ibrahim R, Lemoine A, Bertoglio J, Raingeaud J. Int J Biochem Cell Biol; 2015 Jul 15; 64():45-57. PubMed ID: 25817040 [Abstract] [Full Text] [Related]
16. The effect of epidermal growth factor receptor variant III on glioma cell migration by stimulating ERK phosphorylation through the focal adhesion kinase signaling pathway. Liu M, Yang Y, Wang C, Sun L, Mei C, Yao W, Liu Y, Shi Y, Qiu S, Fan J, Cai X, Zha X. Arch Biochem Biophys; 2010 Oct 15; 502(2):89-95. PubMed ID: 20650261 [Abstract] [Full Text] [Related]
19. Targeting of focal adhesion kinase by flavonoids and small-interfering RNAs reduces tumor cell migration ability. Huang YT, Lee LT, Lee PP, Lin YS, Lee MT. Anticancer Res; 2005 Oct 15; 25(3B):2017-25. PubMed ID: 16158939 [Abstract] [Full Text] [Related]
20. PKC-regulated myogenesis is associated with increased tyrosine phosphorylation of FAK, Cas, and paxillin, formation of Cas-CRK complex, and JNK activation. Goel HL, Dey CS. Differentiation; 2002 Aug 15; 70(6):257-71. PubMed ID: 12190987 [Abstract] [Full Text] [Related] Page: [Next] [New Search]